Literature DB >> 8160985

Cerebral vasomotor responsiveness to carbon dioxide is preserved during propofol and midazolam anesthesia in humans.

S Strebel1, M Kaufmann, P M Guardiola, H G Schaefer.   

Abstract

Carbon dioxide reactivity, as measured by transcranial Doppler ultrasonography, was determined during total intravenous anesthesia with propofol or midazolam in comparison with an awake control group. Thirty ASA physical status I neurosurgical patients undergoing lumbar laminectomy participated in the study. In randomized order they were subjected to a CO2 reactivity challenge, either under an intravenous anesthesia technique or in the awake state. CO2 reactivity was calculated in each study group as a relative change in middle cerebral artery (MCA) flow velocity per mm Hg change in end-tidal CO2 (PETCO2) (%/mm Hg). The cerebrovascular response to changes in CO2 was preserved during intravenous anesthesia. There was a significant difference (P < 0.05) in the reactivity slopes between the awake and the anesthetized patients with a small but not significant difference between the propofol and the midazolam group. We conclude that hypocarbia is effective in reducing cerebral blood flow velocity (CBFV) during intravenous anesthesia, either with propofol or midazolam.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160985     DOI: 10.1213/00000539-199405000-00009

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Combined effects of propofol and mild hypothermia on cerebral metabolism and blood flow in rhesus monkey: a positron emission tomography study.

Authors:  Takashi Ouchi; Ryoichi Ochiai; Junzo Takeda; Hideo Tsukada; Takeharu Kakiuchi
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

2.  Comparison of propofol and desflurane for postanaesthetic morbidity in patients undergoing surgery for aneurysmal SAH: a randomized clinical trial.

Authors:  Avanish Bhardwaj; Hemant Bhagat; Vinod Kumar Grover; Nidhi Bidyut Panda; Kiran Jangra; Seelora Sahu; Navneet Singla
Journal:  J Anesth       Date:  2018-03-01       Impact factor: 2.078

3.  10 cm H2O PEEP application in laparoscopic surgery and cerebral oxygenation: a comparative study with INVOS and FORESIGHT.

Authors:  Perihan Uçar Kemerci; Aslı Demir; Bahar Aydınlı; Çiğdem Yıldırım Güçlü; Ümit Karadeniz; Ömer Faruk Çiçek; İrfan Taşoğlu; Ayşegül Özgök
Journal:  Surg Endosc       Date:  2015-06-23       Impact factor: 4.584

4.  Effect of mild hypocapnia on hemodynamic and bispectral index responses to tracheal intubation during propofol anesthesia in children.

Authors:  Hyun Jeong Kwak; Ji Young Kim; Kyung Cheon Lee; Hong Soon Kim; Jong Yeop Kim
Journal:  J Clin Monit Comput       Date:  2014-02-14       Impact factor: 2.502

5.  Effects of topical and intravenous JM-1232(-) infusion on cerebrovascular reactivity in rats.

Authors:  Kenji Iwata; Hiroki Iida; Mami Iida; Naokazu Fukuoka; Kazuhiro Kito; Kumiko Tanabe
Journal:  J Anesth       Date:  2015-04-26       Impact factor: 2.078

6.  Prospective observational cohort study of cerebrovascular CO2 reactivity in patients with inflammatory CNS diseases.

Authors:  D Lepur; M Kutleša; B Baršić
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-29       Impact factor: 3.267

7.  Sustained moderate reductions in arterial CO2 after brain trauma time-course of cerebral blood flow velocity and intracranial pressure.

Authors:  Luzius A Steiner; Marcella Balestreri; Andrew J Johnston; Marek Czosnyka; Jonathan P Coles; Doris A Chatfield; Peter Smielewski; John D Pickard; David K Menon
Journal:  Intensive Care Med       Date:  2004-10-12       Impact factor: 17.440

8.  Non-pulsatile blood flow is associated with enhanced cerebrovascular carbon dioxide reactivity and an attenuated relationship between cerebral blood flow and regional brain oxygenation.

Authors:  Cecilia Maria Veraar; Harald Rinösl; Karina Kühn; Keso Skhirtladze-Dworschak; Alessia Felli; Mohamed Mouhieddine; Johannes Menger; Ekaterina Pataraia; Hendrik Jan Ankersmit; Martin Dworschak
Journal:  Crit Care       Date:  2019-12-30       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.